Human IFN gamma ELISpot Pair

Datasheet

Catalog Number: 869.060.010

Skip to the end of the images gallery

Skip to the beginning of the images gallery

Key Features

Species Reactivity :

Human

Application :

ELISpot

SKU Price(USD) Size Qty

869060010_10 x 96 $937.78 10 x 96

Qty:

+ -

Custom Quote

Bulk or bespoke? We IVDo that
Request a call back
to discuss your information requirements

Key Documents

Human IFNγ ELISpot Pair - Instructions for use

Product Overview

Product Name	Human IFN gamma ELISpot Pair
Catalog Number	869.060.010
Description	Diaclone ELISpot matched antibody pairs are extensively validated and include pre-titrated capture antibody and biotinylated detection antibody. Antibodies are supplied in quantities sufficient for 10 x 96 samples.
Application	ELISpot
Alternative Names	(click to expand) IFN-g, IFN-gamma

Further Specification

Cross Reactivity	No cross reactivity with other human cytokines. Cross reactivity with simian IFN-g.
Specificity	Recognizes natural human IFN-g

Storage and Shipping

Storage	Store at +4°C
Shipping	Room temperature

References

PubMed	Frange, P. et al., Front Immunol. 2021; 12: 662894. - Pubmed link Samri A. et al., J. Virol., 2000; 74(19): 9306 - 9312 - Pubmed link Carcelain G. et al., J. Virol., 2001; 75(1) : 234 - 241 - Pubmed link Mohty M. et al., Bone Marrow Transplant., 2004;33(8): 839-846 - Pubmed link Scarpellini P. et al. J. Clin. Microbiol., 2004; 42(8): 3469 - 3474 - Pubmed link Speiser D.E. et al., J. Clin. Invest., 2005; 115(3): 739 - 746 - Pubmed link Guihot, A. et al., J Infect Dis.,2006;194(8):1078-88 - Pubmed link Bricaire, F. et al., Bull Acad Natl Med.,2006;190(4-5):1035-46; discussion 1046-9 - Pubmed link Guihot, A. et al., Blood,2007; 111:1387-1395 - Pubmed link Vogt, A. et al., J. Immunol.,2008; 180(3): 1482-1489. - Pubmed link Speiser, D. E. et al., PNAS,2008; 105(10): 3849-3854. - Pubmed link Wang, X.-F. et al., J. Immunol.,2008; 181(1): 431-439. - Pubmed link Garcia, F. et al.,The Journal of Infectious Disease,2011; 203(4): 473-478 - Pubmed link García, F. et al., Science Translational Medicine, 2013;5:166ra2 - Pubmed link Andres, C. et al., J. Virol.,2015;89(18): 9189-9199 - Pubmed link Terrazzini,N. et al.,J Infect Dis.,2018 May 25;217(12):1997-2007 - Pubmed link Scholzen, A. et al., Front Immunol. 2019 Feb 15;10:207. - Pubmed link Nakid-Cordero, C. et al., PLoS One. 2019 Oct 22;14(10):e0224211. - Pubmed link Pilmis, B. et al., Infect Dis Now. 2022 Mar; 52(2): 68–74. - Pubmed link

PubMed

Frange, P. et al., Front Immunol. 2021; 12: 662894. - Pubmed link
Samri A. et al., J. Virol., 2000; 74(19): 9306 - 9312 - Pubmed link
Carcelain G. et al., J. Virol., 2001; 75(1) : 234 - 241 - Pubmed link
Mohty M. et al., Bone Marrow Transplant., 2004;33(8): 839-846 - Pubmed link
Scarpellini P. et al. J. Clin. Microbiol., 2004; 42(8): 3469 - 3474 - Pubmed link
Speiser D.E. et al., J. Clin. Invest., 2005; 115(3): 739 - 746 - Pubmed link
Guihot, A. et al., J Infect Dis.,2006;194(8):1078-88 - Pubmed link
Bricaire, F. et al., Bull Acad Natl Med.,2006;190(4-5):1035-46; discussion 1046-9 - Pubmed link
Guihot, A. et al., Blood,2007; 111:1387-1395 - Pubmed link
Vogt, A. et al., J. Immunol.,2008; 180(3): 1482-1489. - Pubmed link
Speiser, D. E. et al., PNAS,2008; 105(10): 3849-3854. - Pubmed link
Wang, X.-F. et al., J. Immunol.,2008; 181(1): 431-439. - Pubmed link
Garcia, F. et al.,The Journal of Infectious Disease,2011; 203(4): 473-478 - Pubmed link
García, F. et al., Science Translational Medicine, 2013;5:166ra2 - Pubmed link
Andres, C. et al., J. Virol.,2015;89(18): 9189-9199 - Pubmed link
Terrazzini,N. et al.,J Infect Dis.,2018 May 25;217(12):1997-2007 - Pubmed link
Scholzen, A. et al., Front Immunol. 2019 Feb 15;10:207. - Pubmed link
Nakid-Cordero, C. et al., PLoS One. 2019 Oct 22;14(10):e0224211. - Pubmed link

Pilmis, B. et al., Infect Dis Now. 2022 Mar; 52(2): 68–74. - Pubmed link